| Predicate |
Object |
| contentType |
Comment|Journal Article |
| endingPage |
649 |
| issn |
1743-4297
1743-4300 |
| issueIdentifier |
12 |
| pageRange |
648-649 |
| publicationName |
Nature clinical practice. Cardiovascular medicine |
| startingPage |
648 |
| bibliographicCitation |
Gawaz M. Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD? Nature Clinical Practice Cardiovascular Medicine. 2006 Dec;3(12):648–9. doi: 10.1038/ncpcardio0690. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72fad22db330f7408cd5126b84e14fa5 |
| date |
200612 |
| identifier |
https://doi.org/10.1038/ncpcardio0690
https://pubmed.ncbi.nlm.nih.gov/17122794 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32523
https://portal.issn.org/resource/ISSN/1743-4300
https://portal.issn.org/resource/ISSN/1743-4297 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD? |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918456 |